Literature DB >> 6318243

Feeding suppression induced by intra-ventricle III infusion of 1,5-anhydroglucitol.

K Tsutsui, T Sakata, Y Oomura, K Arase, M Fukushima, Y Hinohara.   

Abstract

1,5-Anhydroglucitol (1-DG) has been known as an antimetabolic glucose analogue. Using gas chromatography, 1-DG was found to be physiologically present in rat serum. In order to investigate its direct and long-term effects on feeding, 1-DG was infused during the light period into the rat third ventricle in doses of 3.0, 6.0 and 12.0 mumol/rat. Its effects were then compared to those of similarly applied 2-deoxy-D-glucose (2-DG). Following initial hyperphagia, both of these glucose-analogues produced suppressive effects on feeding during the subsequent day throughout the light and dark periods. On the third day after 2-DG injection reduction of feeding did not recover completely to the pretreatment baseline levels, but it did recover after 1-DG. Both 1-DG and 2-DG caused linear dose-related hypophagia, with the slope for 1-DG being about half of that for 2-DG. It is suggested that the delayed hypophagia which followed the initial hyperphagia produced by deoxyglucose was a result of sustained inactivation of the Na-pump due to intracellular ATP deficiency caused by accumulation of deoxy-glucose-6-phosphate.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6318243     DOI: 10.1016/0031-9384(83)90072-0

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  2 in total

1.  Comparing neuroprotective effects of CDNF-expressing bone marrow derived mesenchymal stem cells via differing routes of administration utilizing an in vivo model of Parkinson's disease.

Authors:  Mei Jiaming; Chaoshi Niu
Journal:  Neurol Sci       Date:  2014-08-27       Impact factor: 3.307

Review 2.  Hypothesis: A Novel Neuroprotective Role for Glucose-6-phosphatase (G6PC3) in Brain-To Maintain Energy-Dependent Functions Including Cognitive Processes.

Authors:  Gerald A Dienel
Journal:  Neurochem Res       Date:  2020-08-19       Impact factor: 3.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.